Substituted pyrrolidinone as inhibitors of hepatitis C NS5B polymerase, the pharmaceutical composition thereof and their therapeutic use

Details for Australian Patent Application No. 2010270153 (hide)

Owner Vivalis

Inventors Berecibar, Amaya; Guedat, Philippe; Valarche, Isabelle; Mohamed-Arab, Celine; Matt, Christophe

Agent Freehills

Pub. Number AU-A-2010270153

PCT Pub. Number WO2011/004018

Priority 09305670.3 10.07.09 EP

Filing date 9 July 2010

Wipo publication date 13 January 2011

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/004018 Priority application(s): WO2011/004018

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010270163-TLR3 binding agents

2010270152-1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis C NS5B polymerase, the pharmaceutical composition thereof and their therapeutic use